UnitedHealth Group raised its full-year adjusted earnings outlook to at least $20.50 a share after reporting third-quarter adjusted earnings of $4.69 a share, ahead of outside expectations. The increase moves the company above its prior adjusted-EPS range of $19.50 to $20 and offers a closely watched reading on whether the insurer is gaining ground against high medical utilization and claims costs.
The company reported $112.69 billion in third-quarter revenue and net income of $4.11 billion, or $4.56 a share, according to CNBC’s account of the results. Shares rose about 3% in premarket trading following the report, a time-specific reaction rather than a measure of the stock’s longer-term valuation. The figures were independently corroborated in an Associated Press earnings snapshot carried by Yahoo Finance.
Profit comparison requires separating adjusted and GAAP figures
The $4.69 figure is adjusted earnings per share, the measure used in comparisons with analyst forecasts and in UnitedHealth’s upgraded outlook. It is not the same as the company’s reported GAAP profit of $4.56 a share. Keeping the two measures separate is important: adjusted results can exclude specified items, while GAAP net income reflects the company’s earnings under standard accounting rules.
On the GAAP basis reported by CNBC, net income rose from $2.35 billion, or $2.59 a share, in the year-earlier quarter to $4.11 billion, or $4.56 a share. The year-over-year increase in per-share GAAP income was roughly 76%, based on those figures, though the available reports do not break out every driver of that change.
There is a small but meaningful data-provider difference in the consensus benchmark. CNBC cited an LSEG estimate of $4.14 a share, while the AP snapshot and a separate Yahoo Finance report based on Investing.com coverage cited $4.12. Both comparisons show that the reported $4.69 adjusted result exceeded expectations; the differing estimates mean the precise size of the beat should not be overstated as a single definitive number.
Medical care ratio came in below expectations
Investors also focused on UnitedHealth’s 88.4% medical care ratio for the quarter. The ratio measures medical claims costs as a percentage of premium revenue. A lower ratio generally indicates that a smaller portion of each premium dollar is being paid out for medical care, leaving more room to cover administrative costs and profit.
The result was below the 89.9% expectation cited by StreetAccount in CNBC’s report, a 1.5-percentage-point difference. That comparison is relevant to insurance profitability, but it should not be applied to UnitedHealth’s $112.69 billion consolidated revenue total: the ratio’s denominator is premium revenue, not all company revenue, which also includes its healthcare-services operations.
The lower-than-expected ratio does not mean medical costs have receded as a business issue. Chief Financial Officer Wayne DeVeydt told CNBC that elevated costs remain a factor. He also said the federal No Surprises Act’s independent-dispute-resolution process is adding at least 100 basis points, or one percentage point, to total medical costs and could place upward pressure on consumer premiums.
Guidance lifts the bar for the fourth quarter
UnitedHealth’s new target of at least $20.50 in adjusted earnings per share represents an increase of at least 50 cents from the high end of its former $19.50-to-$20 range. The wording also leaves open the possibility of a higher final result, while setting $20.50 as the floor management expects to clear.
The outlook is more consequential than a single-quarter beat because it signals that management expects sufficient earnings through the remainder of the year to support a higher full-year result despite persistent cost pressures. CNBC characterized the company’s performance as its third consecutive strong quarter of 2026, while the AP snapshot reported the same $20.50 full-year per-share expectation without distinguishing adjusted from GAAP earnings. UnitedHealth’s own framing, as reported by CNBC, is adjusted earnings.
Management has pointed to value-based care arrangements and AI-enabled operating tools as aids to managing medical costs. Those are executive assessments rather than independently demonstrated causes of the quarter’s ratio result. The reported numbers do show an insurer whose claims-cost measure beat expectations; whether that improvement persists will depend on medical utilization, reimbursement disputes and the company’s ability to execute its broader operating strategy.
